Daniel Tietze

Daniel Tietze is a Senior Scientist for New Modalities at AstraZeneca, where they leverage over ten years of experience in interdisciplinary research, particularly in biochemistry, analytical chemistry, and medicinal chemistry. Prior to this role, Daniel served as a Senior Researcher at Göteborgs universitet and led an independent junior research group at Technische Universität Darmstadt, focusing on small peptides and proteins' dynamics. Daniel holds a PhD in Physical Chemistry from Friedrich-Schiller-Universität Jena, awarded summa cum laude, and has additional postdoctoral experience in solid-state NMR from Iowa State University. With expertise in structure determination and a strong background in protein-peptide interactions, Daniel effectively communicates results and drives collaborative lab work across diverse research groups.